MedPath

A Randomised control trial to look at antibiotic prophylaxis in operative vaginal delivery.

Not Applicable
Conditions
Health Condition 1: O860- Infection of obstetric surgical woundHealth Condition 2: O861- Other infection of genital tract following deliveryHealth Condition 3: O85- Puerperal sepsisHealth Condition 4: O864- Pyrexia of unknown origin following deliveryHealth Condition 5: O862- Urinary tract infection followingdelivery
Registration Number
CTRI/2022/08/044547
Lead Sponsor
Christian Medical College and Hospital Vellore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Women aged 16 years or above, willing and able to give informed consent.

2.Women who have had an operative vaginal delivery at 36+0 completed weeks or greater gestation.

Exclusion Criteria

1.Clinical indication for continuation of antibiotic administration post-delivery

2.Known allergy to penicillin or to any of the components of co-amoxiclav, as previously identified

3.History of anaphylaxis to another �²-lactam agent (e.g. cephalosporin, carbapenem or monobactam)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath